Advanced O3b satellite network cost effectively delivers fiber like connectivity

St. Helier, Jersey, Channel Islands/Washington DC, USA, March 9, 2016- O3b Networks and SpeedCast International Limited (ASX: SDA) have announced an agreement to provide connectivity over the innovative O3b satellite network. The service will be provided to consumers, businesses and government customers by Amalgamated Telecom Holdings (Kiribati) Limited (ATHKL), a subsidiary of Amalgamated Telecom Holdings of Fiji.                  

The Republic of Kiribati has a population of about 100,000 living on 33 atolls and islands, across 3.5 million square km of ocean. O3b is the ideal solution, as the dispersed geography makes laying undersea fibre cables unreasonably expensive and time-consuming. Existing geostationary (GEO) satellites can’t match the O3b network’s high throughput and low latency, which is necessary for modern e-commerce, e-government, e-education and e-Health applications.

SilverCrest (TSXV: SIL.V) Announces Historic Las Chispas Mine Rehabilitation and Drilling; Huasabas Project Update

Vancouver - March 2, 2016 (Investorideas.com Newswire) SilverCrest Metals Inc. (TSXV: $SIL.V) ("SilverCrest" or the "Company") is pleased to announce that it has started rehabilitation of several historic silver-gold mines at its Las Chispas Project ("Las Chispas") located in Sonora, Mexico. Las Chispas is in a prolific mining area which includes current precious metal producers Santa Elena Mine (operated by First Majestic Silver Corp.) and Mercedes Mine (operated by Yamana Gold Inc.). The Company is currently exploring the Las Chispas area to assess the potential for new economic discoveries. All amounts are in Canadian dollars. Please refer to the Company's website at www.silvercrestmetals.com for further information.

N. Eric Fier , CPG, P.Eng, President & CEO stated, "Las Chispas is a very exciting brownfields exploration story. The project area consists of a district size target with multiple historic surface and underground mines that reportedly produced an estimated 100 million ounces of silver and 200 thousand ounces of gold between 1880 and 1930.

Denis Corin, President and CEO of Q BioMed Inc. (OTCQB: QBIO) Talks to Daniel Levine of the Bio Report

Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordability; Perspective on the fallout from Shkreli

March 2, 2016 - Investorideas.com a global digital media source covering leading sectors including biotech stocks profiles the following biotech interview. Denis Corin, President and CEO of Q BioMed Inc. (OTCQB: QBIO) talks with Daniel Levine of the Bio Report about some recent controversial topics in the sector. 

The Bio Report Podcast Overview:

The embattled pharma executive Martin Shkreli, whether intentional or not, has ignited a long smoldering public policy discussion about the pricing of pharmaceuticals. As there are growing calls for steps to restrain drug prices, there are also industry concerns about the effect such actions would have on the ability to attract investment and pursue the development of high-risk, innovative therapies. We spoke to Denis Corin, CEO of Q BioMed, an acceleration and development company, for a perspective on the fallout from Shkreli, how to balance innovation with affordability, and whether he expects any lasting impacts on small drug developers.

CEO Provides Corporate Overview in an Interview With Scrip Intelligence: Developments in Vascular Therapeutics

Mike Ward Global Director of Content, Informa Pharma Insights discusses Q BioMed with Denis Corin in San Francisco at the BioTech Showcase 2016

NEW YORK, NY - February 29, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company is pleased to share the recently published video interview from the Biotech Showcase conference which took place in San Francisco in January 2016.

In the video, CEO Denis Corin is interviewed by Mike Ward, Chief Content Officer, Datamonitor Healthcare & Scrip Intelligence at Informa. Denis discusses the Q BioMed business strategy and recent corporate developments. Watch the interview here: http://www.partnering360.com/insight/showroom/id/736

We invite our shareholders and interested parties to subscribe to our email list and stay informed on our website at http://www.qbiomed.com and follow us on the social media feeds we use.